Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Xing

Showing results (891-900 of 914) with videos related to

Pageof 92
Sort By:
Cancer Letters|January 7, 2020
Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancersYun Wang, Jia-Huan Lu, Feng Wang, et al.
Metabolism: Clinical and Experimental|April 14, 2017
Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolismYan Wang, Jia-Wen Shou, Xiao-Yang Li, et al.
Bioactive Materials|December 23, 2021
Construction of a niche-specific spinal white matter-like tissue to promote directional axon regeneration and myelination for rat spinal cord injury repairBi-Qin Lai, Yu-Rong Bai, Wei-Tao Han, et al.
Molecular Cancer|December 4, 2019
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancerYun Wang, Jia-Huan Lu, Qi-Nian Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complexYanxun Lin, Huan Jin, Yong She, et al.
Cancer Communications (London, England)|October 14, 2023
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancerShu-Qiang Yuan, Run-Cong Nie, You-Sheng Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2026
Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphomaElena Garralda, Patrick Schöffski, Arjun Oberoi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> AmplificationSiqing Fu, Shuyang Yao, Yuan Yuan, et al.
Signal Transduction and Targeted Therapy|September 9, 2020
VDR-SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironmentPei-Shan Hu, Ting Li, Jin-Fei Lin, et al.
Endoscopy|February 27, 2024
Artificial intelligence-assisted system for the assessment of Forrest classification of peptic ulcer bleeding: a multicenter diagnostic studyXiao-Jian He, Xiao-Ling Wang, Tian-Kang Su, et al.
Pageof 92

Showing results (891-900 of 914) with videos related to

Sort By:
Pageof 92
Cancer Letters|January 7, 2020
Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancersYun Wang, Jia-Huan Lu, Feng Wang, et al.
Metabolism: Clinical and Experimental|April 14, 2017
Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolismYan Wang, Jia-Wen Shou, Xiao-Yang Li, et al.
Bioactive Materials|December 23, 2021
Construction of a niche-specific spinal white matter-like tissue to promote directional axon regeneration and myelination for rat spinal cord injury repairBi-Qin Lai, Yu-Rong Bai, Wei-Tao Han, et al.
Molecular Cancer|December 4, 2019
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancerYun Wang, Jia-Huan Lu, Qi-Nian Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 30, 2025
CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complexYanxun Lin, Huan Jin, Yong She, et al.
Cancer Communications (London, England)|October 14, 2023
Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancerShu-Qiang Yuan, Run-Cong Nie, You-Sheng Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2026
Phase I/Ib study evaluating safety, efficacy, pharmacokinetics and pharmacodynamics of NIZ985 monotherapy and in combination with an anti-PD-1 agent in patients with advanced solid tumors or lymphomaElena Garralda, Patrick Schöffski, Arjun Oberoi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> AmplificationSiqing Fu, Shuyang Yao, Yuan Yuan, et al.
Signal Transduction and Targeted Therapy|September 9, 2020
VDR-SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironmentPei-Shan Hu, Ting Li, Jin-Fei Lin, et al.
Endoscopy|February 27, 2024
Artificial intelligence-assisted system for the assessment of Forrest classification of peptic ulcer bleeding: a multicenter diagnostic studyXiao-Jian He, Xiao-Ling Wang, Tian-Kang Su, et al.
Pageof 92